View Information Collection Request (ICR) Package

Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.

View Generic ICR - OIRA Conclusion

OMB Control No: 0920-1158	ICR Reference No: 202001-0920-013
Status: Historical Active	Previous ICR Reference No: 201611-0920-005
Agency/Subagency: HHS/CDC	Agency Tracking No: 16AOW
Title: Ideation Catalyst (I-Catalyst) Program and Customer Engagement Information Collection
Type of Information Collection: Revision of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 02/12/2021
	Date Received in OIRA: 01/28/2020
Terms of Clearance: Approved consistent with the understanding that collections submitted under this Generic will be conducted by CDC I-Catalyst project teams. These collections aim to solicit information from specific stakeholder groups that will collect qualitative outcomes intended to be utilized internally and not generalizable to broader populations. All substudies submitted under this OMB control number will include an abbreviated supporting statement part A (and Part B if necessary) and confirm that no incentives will be provided to responding participants. CDC shall also ensure that respondents are informed that their response is voluntary, as required by 5 CFR 1320.8(b)(3)(iv).

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	02/29/2024	36 Months From Approved	02/28/2021
Responses	1,500	0	3,000
Time Burden (Hours)	750	0	1,500
Cost Burden (Dollars)	43,740	0	87,480

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion
Annual Number of Responses	1,500	3,000	-1,500
Annual Time Burden (Hours)	750	1,500	-750
Annual Cost Burden (Dollars)	43,740	87,480	-43,740

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: Based on utilization during the initial 3-year clearance period, CDC is decreasing the estimated usage of this generic clearance during the next 3-year clearance period.

Annual Cost to Federal Government: $123,000

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

Agency Contact: Renita Macaluso 770 488-6458 arp5@cdc.gov

Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.